108 related articles for article (PubMed ID: 11554172)
1. High resolution immunophenotypic analysis of chronic lymphocytic leukemic cells by enzymatic amplification staining.
Kaplan D; Meyerson H; Lewandowska K
Am J Clin Pathol; 2001 Sep; 116(3):429-36. PubMed ID: 11554172
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders.
McCarron KF; Hammel JP; Hsi ED
Am J Clin Pathol; 2000 Jun; 113(6):805-13. PubMed ID: 10874881
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line.
Minuzzo S; Indraccolo S; Tosello V; Piovan E; Cabrelle A; Trentin L; Semenzato G; Amadori A
Br J Haematol; 2005 Sep; 130(6):878-89. PubMed ID: 16156858
[TBL] [Abstract][Full Text] [Related]
4. Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia.
Shen PU; Fuller SG; Rezuke WN; Sherburne BJ; DiGiuseppe JA
Am J Clin Pathol; 2001 Dec; 116(6):905-12. PubMed ID: 11764081
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotypic analysis with enhanced sensitivity of detection by enzymatic amplification staining.
Kaplan D; Husel W; Meyerson H
Clin Lab Med; 2001 Dec; 21(4):763-78. PubMed ID: 11770286
[TBL] [Abstract][Full Text] [Related]
6. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
Nelson BP; Variakojis D; Peterson LC
Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
[TBL] [Abstract][Full Text] [Related]
7. A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia.
Zucchetto A; Bomben R; Dal Bo M; Sonego P; Nanni P; Rupolo M; Bulian P; Dal Maso L; Del Poeta G; Del Principe MI; Degan M; Gattei V
J Cell Physiol; 2006 May; 207(2):354-63. PubMed ID: 16331666
[TBL] [Abstract][Full Text] [Related]
8. Typical and atypical chronic lymphocytic leukemia differ clinically and immunophenotypically.
Frater JL; McCarron KF; Hammel JP; Shapiro JL; Miller ML; Tubbs RR; Pettay J; Hsi ED
Am J Clin Pathol; 2001 Nov; 116(5):655-64. PubMed ID: 11710681
[TBL] [Abstract][Full Text] [Related]
9. Biclonal chronic lymphocytic leukemia.
Hsi ED; Hoeltge G; Tubbs RR
Am J Clin Pathol; 2000 Jun; 113(6):798-804. PubMed ID: 10874880
[TBL] [Abstract][Full Text] [Related]
10. CD5-negative, CD10-negative small B-cell leukemia: variant of chronic lymphocytic leukemia or a distinct entity?
Sheikh SS; Kallakury BV; Al-Kuraya KA; Meck J; Hartmann DP; Bagg A
Am J Hematol; 2002 Dec; 71(4):306-10. PubMed ID: 12447961
[TBL] [Abstract][Full Text] [Related]
11. Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b).
Zomas AP; Matutes E; Morilla R; Owusu-Ankomah K; Seon BK; Catovsky D
Leukemia; 1996 Dec; 10(12):1966-70. PubMed ID: 8946938
[TBL] [Abstract][Full Text] [Related]
12. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
13. Chronic lymphocytic leukemia coexisting with chronic myelomonocytic leukemia.
Ferrara F; Del Vecchio L; Antonolfi I; Mele G; Rametta V; Cimino R
Haematologica; 1992; 77(2):171-3. PubMed ID: 1398303
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous manifestation of chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL).
Sokol L; Agosti SJ
Am J Hematol; 2004 Feb; 75(2):107-9. PubMed ID: 14755378
[TBL] [Abstract][Full Text] [Related]
16. Analysis of surface and cytoplasmic immunoglobulin light/heavy chains by flow cytometry using a lysed-whole-blood technique: Implications for the differential diagnosis of B-cell malignancies.
Babusíková O; Stevulová L
Neoplasma; 2004; 51(6):422-30. PubMed ID: 15640950
[TBL] [Abstract][Full Text] [Related]
17. Pan B-cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL).
Monaghan SA; Peterson LC; James C; Marszalek L; Khoong A; Bachta DJ; Karpus WJ; Goolsby CL
Cytometry B Clin Cytom; 2003 Nov; 56(1):30-42. PubMed ID: 14582135
[TBL] [Abstract][Full Text] [Related]
18. Immune phenotype and some enzyme patterns in phorbol ester-induced chronic lymphocytic leukemia cells.
Babusíková O; Mesárosová A; Kusenda J; Koníková E; Klobusická M; Hrivnáková A
Neoplasma; 1995; 42(5):221-6. PubMed ID: 8552199
[TBL] [Abstract][Full Text] [Related]
19. Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells.
Vilpo J; Tobin G; Hulkkonen J; Hurme M; Thunberg U; Sundström C; Vilpo L; Rosenquist R
Eur J Haematol; 2005 Jul; 75(1):34-40. PubMed ID: 15946308
[TBL] [Abstract][Full Text] [Related]
20. [Relevance of cytological and immunophenotypical analysis for the diagnosis of B-cell chronic lymphocytic leukaemia].
Guillaume N; Alimardani G; Capiod JC; Claisse JF
Ann Biol Clin (Paris); 2002; 60(6):673-81. PubMed ID: 12446231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]